Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 6 Sponsors

A9010B — · 877 words Open full page ↗

STATE OF NEW YORK

________________________________________________________________________

9010--B

2025-2026 Regular Sessions

IN ASSEMBLY

August 13, 2025

___________

Introduced by M. of A. ROSENTHAL, GALLAGHER, STECK, SHIMSKY, SIMON --

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Amended — base rate 13%, measured from NY's completed sessions
Momentum +1 53/100 from the pace of recorded action
Time since last action -22 165 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.